Prevalence of anemia before and after initiation of antiretroviral therapy among HIV infected patients at Black Lion Specialized Hospital, Addis Ababa, Ethiopia: a cross sectional study

Table 3 Anemia and its associated factors before ART initiation in HIV positive patients attending Black Lion Specialized Hospital, Addis Ababa, Ethiopia, 2017

Variables	Anemic	Non anemic	X²	P value	AOR (95% CI)
Age(in years)
<30	13 (39.4%)	20 (60.6%)	0.10	0.95	1.13 (0.49–2.63)
30–40	48 (42.5%)	65 (57.5%)			1.02 (0.58–1.78)
>40	46 (42.2%)	63 (57.8%)			1.00
Sex
Male	47 (43.9%)	60 (56.1%)	0.21	0.65	1.09 (0.64–1.86)
Female	60 (40.5%)	88 (59.5%)			1.00
WHO clinical stages
Stage I/II	32 (32%)	68 (68%)	6.70	0.01	1.00
Stage III/IV	75 (48.4%)	80 (51.6%)			1.83 (1.06–3.15)
CD4 count (cells/mm³)
<200	89 (49.4%)	91 (50.6%)	14.07	< 0.001	2.91 (1.57–5.39)
≥200	18 (24%)	57 (76%)			1.00

Numerical data in bold indicates the level of significance (p < 0.05), AOR Adjusted odds ratio, CI Confidence interval, 1.00 = reference group

ISSN: 2052-1839